Of note, although Lapatinib does not recognize c-Kit, it was able to kill HCC-1806 and HCC-70 cells more efficiently than Doxorubicin (IC50 26 vs. 180.5 nM, and 80 vs. 700 nM, respectively) (Table 1). The gene discussed is KIT; the disease is hepatocellular carcinoma.